← Back to Screener
Belite Bio, Inc American Depositary Shares (BLTE)
Price$147.00
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)16.13%
Price vs S&P 500 (4W)-11.86%
VGM Score59.09
Market Capitalization$5.93B
All Metrics
Book Value / Share (Quarterly)$19.59
P/TBV (Annual)7.28x
Indicated Dividend (Annual)$0.00
Price vs S&P 500 (YTD)-20.80%
EPS (TTM)$-2.65
10-Day Avg Trading Volume0.25M
EPS Excl Extra (TTM)$-2.65
EPS (Annual)$-2.31
ROI (Annual)-10.07%
Cash / Share (Quarterly)$12.52
ROA (Last FY)-9.94%
EBITD / Share (TTM)$-2.62
ROE (5Y Avg)-31.64%
Cash Flow / Share (Annual)$-0.94
P/B Ratio7.70x
P/B Ratio (Quarterly)7.28x
Net Income / Employee (Annual)$-1,893,000
Net Interest Coverage (TTM)-574.00x
ROA (TTM)-26.26%
EPS Incl Extra (Annual)$-2.31
Current Ratio (Annual)50.02x
Quick Ratio (Quarterly)49.90x
3-Month Avg Trading Volume0.18M
52-Week Price Return119.65%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$19.58
52-Week High$200.00
EPS Excl Extra (Annual)$-2.31
26-Week Price Return32.06%
Quick Ratio (Annual)49.90x
13-Week Price Return-23.53%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)50.02x
Enterprise Value$5.58B
Revenue / Employee (Annual)$0
Cash / Share (Annual)$12.52
3-Month Return Std Dev46.14%
Net Income / Employee (TTM)$-2,524,500
ROE (Last FY)-10.07%
EPS Basic Excl Extra (Annual)$-2.31
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-2.65
ROI (TTM)-26.87%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$19.58
Price vs S&P 500 (52W)91.45%
Year-to-Date Return-9.87%
5-Day Price Return5.01%
EPS Normalized (Annual)$-2.31
ROA (5Y Avg)-29.68%
Month-to-Date Return-9.41%
EBITD / Share (Annual)$-2.51
ROI (5Y Avg)-31.59%
EPS Basic Excl Extra (TTM)$-2.65
P/TBV (Quarterly)7.28x
P/B Ratio (Annual)7.28x
Book Value / Share (Annual)$19.59
Price vs S&P 500 (13W)-33.28%
Beta-1.22x
Revenue / Share (TTM)$0.00
ROE (TTM)-26.87%
52-Week Low$56.10
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-0.68est. -0.65
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.21
4.21
4.21
4.21
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BLTEBelite Bio, Inc American Depositary Shares | — | — | C | $147.00 |
| LLYEli Lilly & Co. | D | B | B | $1082.20 |
| JNJJohnson & Johnson | C | C | C | $223.51 |
| ABBVABBVIE INC. | D | C | C | $212.93 |
| MRKMerck & Co., Inc. | C | C | C | $115.17 |
| NVSNovartis AG | C | C | C | $145.68 |
| AZNAstraZeneca PLC | D | B | C | $179.71 |
| NVONovo-Nordisk A/S | B | B | C | $44.07 |
| PFEPfizer Inc. | B | C | C | $25.63 |
| ABTAbbott Laboratories | C | C | D | $87.78 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | C | C | C | $34.64 |
About
Belite Bio is a clinical-stage biopharmaceutical company developing novel therapeutics for retinal degeneration and metabolic diseases. Its pipeline includes treatments for age-related macular degeneration, Stargardt disease, nonalcoholic fatty liver disease, type 2 diabetes, and gout.